Downstream Processing

Jan 01, 2005
BioPharm International
Manufacturing changes — such as changes in formulation or source material — can impact a product’s immunogenicity.
Jan 01, 2005
BioPharm International
By BioPharm International Editors
The drive to develop better, faster, and smaller — in other words, more efficient — products is a universal trend in the modern world. This trend has profoundly impacted many industries from microelectronics to packaging equipment. In the biopharmaceutical industry, the need to speed and simplify the long and complex drug manufacturing processes brings additional challenges, such as meeting regulatory requirements.
native1_300x100
lorem ipsum